Sort
59,101 grants matching “hypertension”
INHALED NO FOR THE PREVENTION OF CHRONIC LUNG DISEASE
$1,971,020University Of Colorado Denver · U01 · FY2000 · HL
Stem Cells and Aging
$1,970,013Peter J Quesenberry · Rhode Island Hospital · P20 · FY2019 · GM
Pulmonary Hypertension Breakthrough Initiative
$1,969,871Mark W Geraci · University Of Colorado Denver · R24 · FY2015 · HL
CNS Mechanisms Linking Exercise Training with Energy Balance and Metabolism
$1,967,866Joel K Elmquist · Ut Southwestern Medical Center · P01 · FY2020 · DK
Autonomic Cardiovascular Regulation
$1,966,934David Herlie Robertson · Vanderbilt University · P01 · FY2006 · HL
Clinical, Imaging, and Pathological Studies in the Oldest Old: The 90+ Study
$1,966,822Claudia H. Kawas · University Of California-Irvine · R01 · FY2013 · AG
Dopamine/Angiostensin Receptors in Genetic Hypertension
$1,966,359Robin A Felder · University Of Virginia · P01 · FY2007 · HL
Control of Respiratory Skeletal and Smooth Muscle
$1,965,173Case Western Reserve University · P01 · FY2003 · HL
The POINTER Neurovascular Ancillary Study
$1,964,808Tina E Brinkley · Wake Forest University Health Sciences · R01 · FY2021 · AG
Na+, Ca2+, Arterial Contractility and Ouabain Hypertension
$1,963,394Mordecai P Blaustein · University Of Maryland Baltimore · P01 · FY2008 · HL
The POINTER Neurovascular Ancillary Study
$1,962,437Tina E Brinkley · Wake Forest University Health Sciences · R01 · FY2022 · AG
The POINTER Neurovascular Ancillary Study
$1,962,435Tina E Brinkley · Wake Forest University Health Sciences · R01 · FY2023 · AG
Vascular remodeling in patients with rare genetic disorders
$1,961,950Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL
Autonomic Cardiovascular Regulation
$1,961,341Vanderbilt University · P01 · FY2005 · HL
Autonomic Cardiovascular Regulation
$1,959,509David Herlie Robertson · Vanderbilt University · P01 · FY2008 · HL
Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. Coli Infection (HIKO STEC): A Multinational, Embedded, Cluster, Crossover, Randomized Trial
$1,959,301Stephen Bradley Freedman · University Of Calgary · R01 · FY2024 · AI
Na+, Ca2+, Arterial Contractility & Quabain Hypertension
$1,957,494Mordecai P Blaustein · University Of Maryland Baltimore · P01 · FY2006 · HL
Development of a Novel Hyaluronan Inhibitor for the Treatment of Group 3 Pulmonary Hypertension (PH)
$1,957,305Rudy Paladini · Halo Biosciences, Inc. · R44 · FY2024 · HL
Framingham Heart Study/Fox
$1,956,697Caroline Fox · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
CNS Mechanisms Linking Exercise Training with Energy Balance and Metabolism
$1,956,416Joel K Elmquist · Ut Southwestern Medical Center · P01 · FY2021 · DK
Therapeutic Targeting of the Myofibroblast in Fibrotic Lung Disease
$1,956,371Victor John Thannickal · University Of Alabama At Birmingham · P01 · FY2017 · HL
Therapeutic Targeting of the Myofibroblast in Fibrotic Lung Disease
$1,956,371Victor John Thannickal · University Of Alabama At Birmingham · P01 · FY2016 · HL
General Clinical Research Center
$1,956,242David A Kessler · University Of California, San Francisco · M01 · FY2006 · RR
Blood Pressure Regulation: Novel Roles for the Kidney
$1,955,769Pablo A Ortiz · Henry Ford Health System · P01 · FY2013 · HL
Hopkins Center for Eliminate Cardiovascular Health Disparities
$1,954,879Lisa A Cooper · Johns Hopkins University · P50 · FY2014 · HL